
--- Page 1 ---
1Cs -0-3 Collection Date: 850 S1K: Bnast, Nos C50.9 UUID:F70DE761-F081-4F4C-AD22-9A166CF78CA8 TCGA-BH-A1F5-01A-PR Redacted PATIENT HISTORY: The patlent is a  -old female. Date of last menstrual period: Not given. PRE OP DIAGNOSIS: Breast cancer. POST OP DIAGNOSIS: Same. PROCEDURE: Right sentinel node biopsy, right segmental mastectomy.. FINAL DIAGNOSIS: Part 1: Right SentineL Lymph NOde #1, BIOpsy - One Lymph noDe, negative for tumor (0/1). Part 2: Right nOn-sentinel Lymph noDe #2, BiOpsy -- FIBrOaDipose tissue, nO Lymph noDe identifieD. Part 3: Right non-sentinel Lymph node #1, BiOpsy -- ONE LYmPH NODE, NEGATIVE FOR TUMOR (0/1). PARt 4: Right nON-SEnTIneL Lymph nODE #3, BIOpSy --  ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). Part 5: Right Sentinel Lymph nODe #2, bIOpsy - One Lymph nODE, nEGAtiVE FOR TUmOR (0/1). Part 6: Right SentineL Lymph nOde #3, biOpSy -- ONE LyMPH nODE, NEGATIVE FOR TUMOR (0/1). Part 7: Right breast, Biopsies x 4 - A. ONE OUt OF 4 Lymph nODeS POSITIVE fOR mEtAStaTIC CARCInOmA (1/4). 8. Benign FibroaDipOse tissue (see comment). Part 8: Right breast, segmental mastectomy - A.  Infiltrating Duct CarcinomA. 1.4 Cm in greatest Dimension As measured On the SliDe, NOTTiNGHAm SCORE 7/9 (TUBULES 3, nUCLEI 3, MITOSIS 1) ASSOC!ATED WITH MICROCALCIFICATIONS. B. LYMPHOVASCULAR INVASION IDENTIFIED. C. DUctal CARcinoma In SiTU, SOLid And CriBrifORm typE, nUcleaR GRADe 2 aSsOciated wiTH MICROCAI FICAT!ONS AND COMPRISING LESS THAN 5% OF TUMOR. D. SURGICAL MARGINS NEGATIVE. INFI DUCT CARCINOMA APPROACHES ANTERIOR MARGIN WITHIN O.3 CM.E F. Changes Consistent with previous core Biopsy Site. G TumOR iS eStROgen RECeptOR POsItive, PrOgeSterOne rEcEptOr PosITJye AnD hER-2/NeU NegaIye as per previous core biopsy report. H. UNREMARKABLE SKIN. I. FIBROCYSTIC CHANGES. COMMENT: One lymph node in specimen number 7 contains micrometastatic carcinoma that measures iess than 0.2 cm in diameter.

--- Page 2 ---
MICROSCOPIC: SYNOPTIC : PRIMARY iNVASIVE CARCINOMA OF BREAST A. Laterality: 1 1. Right 2. Left B. Procedure: 1 1. Segmentectomy 3. Modified radical mastectomy 2. Simple mastectomy 4. Re-excision C. Location:  1. Central subareolar 4.L0Q 2. U0Q 5.LIQ 3. UIQ 6. Not specified O. Size of tumor (maximum dimension invasive component by gross or microscopic exam): 1.4 cm E. Type (invasive component): 1 1. Ductal, NOS 5. Cribriform 9. Metaplastic 2. Tubular 8. Papillary 10. Other 3. Mucinous 7. Lobular 4. Medullary 8. Carcinoid like F. if lobular carcinoma, specify type:  N/A. 1. Classical 4. Signet ring 7. Pleomorphic 2. Solid 5. Trabecuiar  3. Alveolar 6. Tubulobular G. Nottingham Score:e G1. Nuclear grade: 3 G2. Tubule formation: 3 G3. Mitotic activity score: 1 G4. Total Nottingham score: 7 G5. Nottingham grade (1, 2, 3): # H. Angiolymphatic invasion: 2 1. No 2. Yes I. Dermal lymphatic invasion: 2 1. Yes 2. No 3. Not applicable J. Calcification: 3 1. No 2. Yes -- benign zones 3. Yes -- malignant zones K. Type of in situ component: 1/2 1. Cribriform 4. Micropapllary 7. Lobuiar 2. Solid 5. Apocrine 3. Papillary 6. Comedo .  Percentage of tumor occupied by in situ component: 5% M. Surgical margins involved by invasive component: 1 1 No 2. Yes -- focal 3. Yes -- diffuse N. Surgical margins involved by in situ component: 1 1. No 2. Yes -- focal O. Paget's disease of nipple: N/A 3. Yes - diffuse 1. Yes 2. No P. Number of positive lymph nodes:1 Q. Total number of lymph nodes examined: 9. R. Sentinel node metastasis: 2 1. Yes 2. No S. Only micrometastases to lymph nodes (none larger than 0.2 cm): 1 1. Yes 2. No T. Metastasis/es to a lymph node 2 cm. or more in greatest dimension: 2 1. Yes 2. No U. Lymph node metastasis/es with extracapsuiar extension: 2 1. Yes 2. No V. Metastases to ipsilateral internal mammary lymph node (if applicable): N/A 1. Yes 2. No W. Skin invoived (ulceration): 2 1. Yes 2. No X. Non-neoplastic breast tissue: 6 1.ADH 4. Fibroadenoma 2. ALH 7. LCiS  5. Papilloma 3. Radical scar 8. Other 6. FCD Y. Multicentricity/multifocality of invasive foci:2 1.Yes 2.No Z. TNM stage: T1c N 1mi M X